Guillaume Cayla, MD, PhD

Original Contribution

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients

07/15/2018

Pierre Robert , MD;

Patrick Messner-Pellenc , MD, PhD;

Florence Leclercq , MD, PhD;

Guillaume Cayla , MD, PhD;

Benoit Lattuca , MD;

David Belardi , MD;

Christophe Demattei , MD;

Laurent Schmutz , MD;

Luc Cornillet , MD;

Bertrand Ledermann , MD;

Jean-Christophe Macia , MD;

A. Lemmi , MD;

Richard Gervasoni , MD;

Francois Roubille , MD, PhD;

Thien Tri Cung , MD;

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before PCI in elective and NSTEMI patients. This study assesses outcomes after performing PCI immediately after coronary angiography with an exclusive...

Recent studies have challenged...

07/15/2018

Journal of Invasive Cardiology

Paclitaxel Drug-Coated Balloon After Bare-Metal Stent Implantation, an Alternative Treatment to Drug-Eluting Stent in High Bleeding Risk Patients (The Panelux Trial)

03/28/2019

Christophe Piot , MD;

Jerome Roncalli , MD, PhD;

Matthieu Godin , MD;

Kamel Boughalem , MD;

John Shayne , MD;

Bruno Huret , MD;

Loic Belle , MD;

Max Amor , MD;

Benjamin Faurie , MD, PhD;

Bernard Karsenty , MD;

Florence Leclercq , MD, PhD;

Guillaume Cayla , MD, PhD;

Prolonged dual-antiplatelet therapy in high bleeding risk (HBR) patients undergoing percutaneous coronary intervention can be challenging. We assessed the clinical safety of bare-metal stent implantation followed by drug-coated balloon...

Prolonged dual-antiplatelet...

03/28/2019

Journal of Invasive Cardiology